or Try an Advanced Search...

    Antacid Stocks List

    Symbol Grade Name % Change
    PBH D Prestige Brand Holdings, Inc. 0.50
    ANIP C ANI Pharmaceuticals, Inc. -0.52
    GSK A GlaxoSmithKline PLC 1.29
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Distribution
    Related Stock Lists: Acid Cough Medicine Oral Care Products Pharmaceutical Abrasives Antibiotics Antiemetics Asthma Body Care Products Cancer Chloroarenes Cleaning Cleaning Agent Cleaning Products Consumer Health Products Contract Manufacturing Contract Manufacturing Services Depression Dermatology

    Related ETFs - A few ETFs which own one or more of the above listed Antacid stocks.

    Symbol Grade Name Weight
    PJP C PowerShares Dynamic Pharmaceuticals 7.95
    PPH C Market Vectors Pharmaceutical ETF 4.58
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 3.97
    VIRS C Pacer BioThreat Strategy ETF 2.95
    FPXI C First Trust International IPO ETF 2.93
    View all Antacid ETFs...
    Compare ETFs
    Compare PJP to VIRS Compare PPH to PSCH Compare PPH to VIRS

        Antacid Stocks Recent News

        Date Stock Title
        May 7 GSK BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
        May 6 GSK GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
        May 6 ANIP ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
        May 5 GSK GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
        May 4 GSK GSK plc (GSK) Q1 2024 Earnings Call Transcript
        May 3 ANIP Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
        May 3 ANIP ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
        May 3 ANIP Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
        May 3 ANIP Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
        May 2 ANIP Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
        May 2 GSK GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 1 ANIP ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
        May 1 GSK GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
        May 1 ANIP GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
        May 1 ANIP How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
        May 1 GSK GSK raises profit guidance as vaccine demand grows
        May 1 GSK GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
        May 1 GSK Trending tickers: Amazon, AMD, GSK and Aston Martin
        May 1 GSK GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwards
        May 1 GSK GSK Lifts Guidance After Turnover Beats Expectations
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Distribution
        Related Stock Lists: Acid Cough Medicine Oral Care Products Pharmaceutical Abrasives Antibiotics Antiemetics Asthma Body Care Products Cancer Chloroarenes Cleaning Cleaning Agent Cleaning Products Consumer Health Products Contract Manufacturing Contract Manufacturing Services Depression Dermatology
        Antacid

        An antacid is a substance which neutralizes stomach acidity and is used to relieve heartburn, indigestion or an upset stomach. Some antacids have been used in the treatment of constipation and diarrhea. Currently marketed antacids contain salts of aluminum, calcium, magnesium, or sodium. Some preparations contain a combination of two salts, such as magnesium carbonate and aluminum hydroxide.

        More about Antacid
        Browse All Tags